You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RSVPreF3 vaccine

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

Not yet recruiting
  • Vaccine Reaction
  • COVID-19
  • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
  • VidPrevtyn® Beta vaccine (Sanofi/GSK)
  • Paris, France
    CIC 1417 Cochin-Pasteur
Feb 28, 2023

Diphtheria, Tetanus and Acellular Pertussis Trial (Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined

Not yet recruiting
  • Diphtheria, Tetanus and Acellular Pertussis
  • Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP)
  • +4 more
  • (no location specified)
Jul 10, 2023

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
  • (no location specified)
May 8, 2023

CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic

Recruiting
  • CIN3
  • +3 more
  • Vvax001 therapeutic cancer vaccine
  • Groningen, Netherlands
    University Medical Center Groningen (UMCG)
Aug 23, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention Trial in Mechelen (ExPEC9V, Placebo, HD

Recruiting
  • Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
  • ExPEC9V
  • +2 more
  • Mechelen, Belgium
    Az Sint-Maarten
Nov 13, 2023

Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral

Not yet recruiting
  • Poliomyelitis
  • Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
  • Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
  • Panama City, Panama
  • +3 more
Dec 14, 2022

COVID-19 Disease & Vaccine Survey in Africa

Recruiting
  • COVID-19
  • Vaccine Hesitancy
  • Questionnaire
  • Surrey, British Columbia, Canada
    Salem Anaesthesia Pain Clinic
Jul 18, 2023

COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus vaccine (CHO Cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 6, 2023

Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide

Recruiting
  • Pneumococcal Disease
  • 23-valent pneumococcal polysaccharide vaccine
  • control pneumococcal polysaccharide vaccine
  • Chengdu, Sichuan, China
    Sichuan Center For Disease Control and Prevention
Sep 19, 2023

Meningococcal Infection (Healthy Volunteers) Trial in Middelburg (Meningococcal Polysaccharide (Serogroups A, C, Y, and W)

Recruiting
  • Meningococcal Infection (Healthy Volunteers)
  • Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
  • +11 more
  • Middelburg, South Africa
    Investigational Site Number: 7100001
Apr 4, 2023

Respiratory Syncytial Virus (RSV) Trial in Rochester (RSV vaccine)

Not yet recruiting
  • Respiratory Syncytial Virus (RSV)
  • RSV vaccine
  • Rochester, New York
    University of Rochester Medical Center
Oct 11, 2023

Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3

Recruiting
  • Immunization
  • +2 more
  • 9-valent HPV vaccine, 2 dose efficacy
  • 9-valent HPV vaccine, 3 doses standard timing
  • Galveston, Texas
    University of Texas Medical Branch
Jan 30, 2023

Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of

Not yet recruiting
  • Meningococcal Meningitis
  • batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
  • +3 more
  • Surabaya, Indonesia
    Husada Utama Hospital
Nov 13, 2023

Rabies Trial in Thai Binh (RABIVAX-S)

Completed
  • Rabies
  • RABIVAX-S
  • Thai Binh, Vietnam
    CDC Thai Binh
Jun 29, 2023

Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)

Not yet recruiting
  • Ebola Sudan Virus Disease
  • cAD3-Sudan Ebolavirus Vaccine
  • Placebo
  • Siaya, Kenya
  • +1 more
Sep 7, 2023

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)

Not yet recruiting
  • Malaria,Falciparum
  • MSP3-CRM-Vac4All/ Alhydrogel®
  • Anti-Rabies Vaccine
  • Bamako, Mali
    Malaria Research and Training Center (MRTC), University of Scien
Mar 7, 2023

COVID-19 Vaccine Trial in Argentina (Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine,

Recruiting
  • COVID-19 Vaccine
  • Gamma Variant RBD-based ARVAC-CG vaccine
  • +3 more
  • Argentina, C.a.b.a., Argentina
    Centro de Educación Médica e Investigaciones Clínicas "Norberto
Feb 28, 2023

Poliomyelitis Trial in United States (Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin

Active, not recruiting
  • Poliomyelitis
  • Novel Oral Polio Vaccine Type 1 (nOPV1)
  • +3 more
  • Baltimore, Maryland
  • +3 more
Aug 24, 2022

Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine)

Not yet recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • (no location specified)
May 16, 2023

Seasonal Influenza Trial in Huai'an (Two doses of quadrivalent influenza vaccine, One dose of quadrivalent influenza vaccine)

Completed
  • Seasonal Influenza
  • Two doses of quadrivalent influenza vaccine
  • One dose of quadrivalent influenza vaccine
  • Huai'an, Jiangsu, China
    Huaiyin Center for Disease Control and Prevention
Aug 9, 2022

SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

Recruiting
  • SARS-CoV-2 Infection
  • B/HPIV3/S-6P
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Aug 30, 2023